Vitruvia Medical AG
Vitruvia Medical AG, a technology company, operates in the healthcare sector. The company supplies circular systems for medical devices primarily in robot-assisted surgery. It also focusses on the repair, production, and trading of medical devices and surgical instruments. Vitruvia Medical AG was incorporated in 2017 and is based in Wohlen, Switzerland.
Market Cap & Net Worth: Vitruvia Medical AG (991)
Vitruvia Medical AG (MU:991) has a market capitalization of $14.74K (€14.36K) as of March 19, 2026. Listed on the MU stock exchange, this Germany-based company holds position #44397 globally and #7275 in its home market, demonstrating a -0.66% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vitruvia Medical AG's stock price €1.50 by its total outstanding shares 9573 (9.57K).
Vitruvia Medical AG Market Cap History: 2021 to 2026
Vitruvia Medical AG's market capitalization history from 2021 to 2026. Data shows change from $157.22K to $14.74K (-42.82% CAGR).
Vitruvia Medical AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vitruvia Medical AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 991 by Market Capitalization
Companies near Vitruvia Medical AG in the global market cap rankings as of March 19, 2026.
Key companies related to Vitruvia Medical AG by market ranking:
- Mobotix AG (F:MBQ): Ranked #44388 globally with a market cap of $14.29K USD ( €13.92K EUR).
- Somero Enterprise Inc (LSE:SOM): Ranked #44389 globally with a market cap of $14.27K USD ( GBX117.32 Million GBX).
- Advanced Biomedical Technologies Inc (PINK:ABMT): Ranked #44398 globally with a market cap of $14.18K USD.
- GreenBank Capital Inc (PINK:GRNBF): Ranked #44399 globally with a market cap of $14.18K USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #44388 | Mobotix AG | F:MBQ | $14.29K | €1.45 |
| #44389 | Somero Enterprise Inc | LSE:SOM | $14.27K | GBX205.00 |
| #44398 | Advanced Biomedical Technologies Inc | PINK:ABMT | $14.18K | $0.00 |
| #44399 | GreenBank Capital Inc | PINK:GRNBF | $14.18K | $0.00 |
Vitruvia Medical AG Historical Marketcap From 2021 to 2026
Between 2021 and today, Vitruvia Medical AG's market cap moved from $157.22K to $ 14.74K, with a yearly change of -42.82%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €14.74K | +50.00% |
| 2025 | €9.83K | 0.00% |
| 2024 | €9.83K | -16.67% |
| 2023 | €11.79K | -47.83% |
| 2022 | €22.60K | -85.62% |
| 2021 | €157.22K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Vitruvia Medical AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.74K USD |
| MoneyControl | $14.74K USD |
| MarketWatch | $14.74K USD |
| marketcap.company | $14.74K USD |
| Reuters | $14.74K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.